Tumour assessment criteria for immune checkpoint inhibitors

Revue des maladies respiratoires
E Wasielewski, A B Cortot

Abstract

The development of immune checkpoint inhibitors in thoracic oncology has led to a reconsideration of the rules for radiological tumor assessment. The RECIST criteria are widely used for the assessment of conventional treatments but are not suitable for anti-tumoral immunotherapy. The mechanism of action of this new class of drugs may induce specific patterns of response, which are not fully assessed by the RECIST criteria. Several new criteria have been proposed to better detect these patterns of response. The changes usually include confirmation of progression, new ways of assessing new lesions, and a larger role for clinical assessment. Nevertheless, harmonization and validation of these criteria remains indispensable. In this review, we will detail the different criteria that are currently available, and discuss their strengths and weaknesses.

Citations

Jan 7, 2020·Médecine sciences : M/S·Manon DuboisLaurent Mortier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Michelle A RudekMark J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Anna GagliardiWilliam K Evans
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jan BogaertsRECIST Working Party
American Journal of Respiratory and Critical Care Medicine
Kenneth B Adler, Edward Abraham
© 2022 Meta ULC. All rights reserved